SM-020 Gel for Seborrheic Keratosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a special gel called SM-020 to see if it can safely and effectively treat Seborrheic Keratosis, a common skin condition. Patients will apply the gel regularly for a few weeks. The goal is to see if the gel can reduce or eliminate the skin growths.
Will I have to stop taking my current medications?
The trial requires participants to stop certain medications before starting. If you're taking retinoids, chemotherapy, or vismodegib, you need to stop 180 days before the trial. Other medications like immunosuppressive therapy, biologics, glucocorticosteroids, and known photosensitizing medications need to be stopped 28 days before.
How does the SM-020 gel drug for seborrheic keratosis differ from other treatments?
The SM-020 gel for seborrheic keratosis is unique because it is specifically formulated as a 1.0% gel, which may offer a novel approach compared to other treatments like dobesilate cream or ingenol mebutate gel used for similar skin conditions. Unlike traditional treatments that may focus on antifungal or anti-inflammatory properties, SM-020 gel's specific formulation and concentration could provide a new mechanism or benefit for treating seborrheic keratosis.12345
Are You a Good Fit for This Trial?
This trial is for adults with Seborrheic Keratosis who have at least 5 affected areas not on eyelids or covered by hair. Participants must understand and sign consent forms, be free of certain diseases, agree to follow study instructions, and attend all visits. Pregnant women or those not using birth control are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants apply the assigned investigational product twice daily for 4 consecutive weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- SM-020 gel 1.0%
- Vehicle gel
Find a Clinic Near You
Who Is Running the Clinical Trial?
DermBiont, Inc.
Lead Sponsor